BARDA
@BARDA
Followers
10,308
Following
226
Media
1,928
Statuses
2,955
Advancing countermeasures against 21st century health threats by bringing together public private partnerships and advancing innovation. Part of HHS/ASPR.
Washington, DC
Joined April 2017
Don't wanna be here?
Send us removal request.
Explore trending content on Musk Viewer
Adams
• 161537 Tweets
Colombia
• 159310 Tweets
#السعوديه_البحرين
• 155236 Tweets
England
• 151427 Tweets
German
• 127045 Tweets
Bloomberg
• 118440 Tweets
سالم
• 94491 Tweets
Tuchel
• 81371 Tweets
Fields
• 62438 Tweets
Portugal
• 52469 Tweets
مانشيني
• 44456 Tweets
Browns
• 42508 Tweets
Amari Cooper
• 37989 Tweets
Krypto
• 37181 Tweets
كاس العالم
• 30530 Tweets
المنتخب السعودي
• 26582 Tweets
علي المنتخب
• 23094 Tweets
Russ
• 18732 Tweets
#فزعه_الشعب_السعودي
• 18544 Tweets
#POLCRO
• 18322 Tweets
#TemptationIsland
• 14075 Tweets
Pinned Tweet
Today as BARDA enters our 16th year, we're releasing a new strategic plan focused on fortifying the nation’s
#HealthSecurity
by enabling a rapid response to
#PublicHealth
emergencies with
#MedicalCountermeasures
that save lives. Learn more:
29
13
43
Through the
@RRPV_Consortium
and
#ProjectNextGen
, we’re partnering with
@castlevaxbio
, Cyanvac, and
@Vaxart
to evaluate novel
#COVID19
vaccine candidates that are needle-free. Learn more:
23
56
246
Two mask designs have been awarded $150,000 each as winners of the
#MaskInnovationChallenge
Phase 2 from BARDA,
@NIOSH
, &
@NIST
. Read the
#BARDAStory
about the designs from winners
@Air99_LLC
&
@ReadiMask
, as well as runners-up
@Flo_Mask
&
@LeviStraussCo
:
5
53
131
Today, we took steps to speed the development and secure domestic manufacturing of two vaccines – one by
@Moderna_tx
& another by
@JanssenUS
- to prevent the spread of
#COVID19
and protect people at home and abroad.
7
46
97
Under
#ProjectNextGen
, we’re advancing the clinical development of next generation COVID-19
#vaccines
that offer broader, longer lasting protection & that are easier to administer & reduce viral spread. This
#NationalVaccinationDay
, learn more:
10
19
95
Under
#ProjectNextGen
, we are partnering with
@Vaxart
on planning a Phase 2b clinical trial that would compare its oral pill
#COVID19
vaccine candidate to a currently approved COVID-19 vaccine. Learn more about Project NextGen:
14
19
79
Mucosal vaccines may have the potential to help prevent infection and transmission of COVID-19. Check out the latest
#BARDAResearch
to learn about progress in development & remaining challenges in getting vaccines to licensure:
17
18
79
BARDA is committed to supporting the next generation of innovative vaccine & therapeutic investments to help protect our nation against coronavirus and other infectious diseases.
18
24
70
We’re excited about Project NextGen which supports vaccine innovation efforts to enhance efficacy & accessibility of vaccines for future pathogens with pandemic potential – they will ideally be developed faster, easier to transport, & cost less compared to current vaccines.
10
16
57
We’re partnering w/
@JPEOCBRND
to provide subject matter expertise to
@humanigen
to support development of a monoclonal antibody therapeutic w/ potential to treat cytokine storm, reducing hospital stays & preventing lung damage from
#COVID19
. Learn more:
8
11
54
We are proud to partner with
@Regeneron
to develop a potential therapeutic needed to
#SaveLives
from
#COVID19
. BARDA is supporting the Phase 2/3 clinical trial for this product.
2
20
52
BARDA joined partner Jubilant HollisterStier for a ribbon-cutting ceremony at their high-speed, commercial fill-finish line facility in Spokane, Washington. This project aims to enable faster domestic production of vaccines during a public health emergency
5
12
48
#ICYMI
we developed a
#sepsis
training module with
@SepsisAlliance
,
@ASPRgov
and
@CDCgov
to help healthcare & EMS professionals recognize and manage at-risk patients in disaster settings. Take the training and see how we’re
#SolvingSepsisTogether
1
19
44
Congratulations to the entire
@Pfizer
team on the 1st COVID-19 vaccine in the US granted with
@US_FDA
emergency use authorization. This EUA allows the BioNTech vaccine purchased by the US government to be shipped across America to those who need it most to
#SaveLives
0
7
43
BARDA is delighted to announce that Gary Disbrow, has accepted the role of permanent BARDA director. Dr. Disbrow has served in many roles since 2007. Please join us in congratulating him as we continue to pursue our mission of addressing 21st century
#HealthSecurity
threats.
4
10
43
.
@Vaxart
announced the initiation of the sentinel cohort of its Phase 2b clinical trial, which we support under
#ProjectNextGen
. The trial will determine the efficacy, safety, & immunogenicity of their oral vaccine candidate. For more on our
#COVID19
work:
2
13
50
We’re partnering w/
@JPEOCBRND
&
@Pfizer
under
#WarpSpeed
on large-scale production & delivery of a
#COVID19
vaccine. With authorization from
@US_FDA
, the millions of doses made could become part of a vaccine campaign to
#SaveLives
.
7
19
42
We’re excited to announce a partnership with Global Health Investment Corporation. The joint endeavor, BARDA Ventures, will use venture capital practices to accelerate innovative technology development to
#SaveLives
& mitigate public health emergencies.
1
16
43
For
#NationalVaccinationDay
, we’re recognizing our
#CBRN
Vaccine Branch’s investments to address multiple public health threats, as well as the importance of flexible vaccination strategies to protect all populations. To learn more, visit:
51
13
37
An important
#ProjectNextGen
focus is advancing next generation therapeutics to treat individuals with
#COVID19
& enable protection against the virus.
#NPM2023
4
11
39
A key goal of
#ProjectNextGen
is to invest in
#COVID19
vaccine and therapeutic candidates that have favorable attributes that potentially increase access to prevention and treatment by better meeting the needs of America’s diverse population.
6
14
38
BARDA is supporting a portfolio of
#COVID19
diagnostics to enable early detection & help
#SaveLives
. This week,
@US_FDA
approved a BARDA-supported rapid, hand-held, point-of-care diagnostic test for SARS-CoV-2 that was developed by
@mesa_biotech
.
1
17
36
📣 Our BID Day 2 Breakout Sessions will cover BARDA’s efforts in supporting the innovation & advancement of
#medicalcountermeasure
development & national preparedness. There will also be opportunities to meet w/ stakeholders about funding & possible partnerships.
3
8
37
We are proud to partner with
@JPEOCBRND
& SAb Biotherapeutics, Inc. to develop a therapeutic treatment for
#COVID19
. This therapeutic uses tech that has the potential to be safer, more effective, & longer lasting than current polyclonal antibody therapies.
5
19
35
Project NextGen will accelerate and streamline research and development of vaccines and therapeutics against
#COVID19
. BARDA &
@NIAIDNews
are collaborating on this effort to spur innovation through public-private partnerships.
5
11
34
🆕 The BARDA Broad Agency Announcement now includes seven areas of interest related to
#COVID19
medical countermeasures, including vaccines, therapeutics, diagnostics and more. Find out about new opportunities for partnership ➡️
#HealthSecurity
0
25
34
Welcome to Sandeep Patel, PhD (
@innovationwonk
), DRIVe’s new director – here to make a difference and help
#SaveLives
with innovative approaches across the spectrum of systemic challenges to ensure our nation’s health security.
5
12
34
When BARDA Director Rick Bright got a minor cut while gardening, he wasn’t expecting it to get infected with MRSA. Find out how that cut & a delayed diagnosis led to the misuse of antibiotics, threatened patient health, increased healthcare costs & more.
0
11
32
Save the date: BARDA Industry Day 2020 Tuesday Oct 27! Spend the day with us during our first fully digital conference and learn how we are Responding Together, Preparing for Tomorrow.
#BARDA2020
9
22
31
Hear from Dr. Robert Johnson, Director of BARDA’s Medical Countermeasures Program, about the effort between BARDA &
@NIAIDNews
to support development of new vaccines & therapeutics to better address
#COVID19
& family of viruses through
#ProjectNextGen
:
10
5
32
Through
#ProjectNextGen
, BARDA, in collaboration with National Institute of Allergy and Infectious Diseases (NIAID), will leverage public-private partnerships to develop new vaccines and therapeutics to enhance our preparedness for future
#COVID19
strains & variants.
4
7
33
Recently published: BARDA is supporting Phase 2b clinical trials of next-generation
#COVID19
vaccines with potential to improve efficacy & safety through
#ProjectNextGen
. Learn about the goals of these BARDA-supported clinical trials & access the article:
0
10
32
Antibiotic resistance is a huge concern of BARDA’s. And it's one we must work together and take an end-to-end approach to solve. No one group has the solution, just as no single antibiotic is a silver bullet.
#HealthSecurity
#AMR
#WorldAMRCongress
@CARB_X
@CMSGov
1
14
28
Today, we are expanding our existing
#PublicPrivatePartnership
with
@JanssenUS
to expedite development of a novel
#coronavirus
vaccine using proven technology.
#COVID19
#2019nCoV
1
19
28
Registration now open! We will host a virtual workshop:
#ProjectNextGen
: Enablers for Innovative COVID-19 Vaccine Manufacturing on July 20, 2023, at 1:00 p.m. ET. Learn more and register:
5
10
31
Under
#ProjectNextGen
, we’re partnering with multiple companies to support acceleration of Phase IIb clinical trial initiation for next generation
#COVID19
booster vaccine candidates and support data collection and statistical analysis:
7
11
31
One of the program areas for Project NextGen is Strengthen: to advance next generation COVID-19 vaccine candidates, including broader, more durable protection, and better transmission blocking capabilities.
2
8
30
Masks have played a critical role in combatting COVID-19. The BARDA,
@NIOSH
&
@NIST
#MaskInnovationChallenge
is accelerating the development of the next generation of masks to protect the public from a variety of airborne threats. Read more:
6
10
29
BARDA will fund
@CARB_X
over the next 10 years, leveraging global partnerships to transform early-stage antibacterial R&D into innovative
#MedicalCountermeasures
that help combat the growing threat of
#AntimicrobialResistance
(
#AMR
).
Read more ⤵️
0
5
29
#MakingCountermeasures
Day 26: A
@ChembioDx
technician runs the DPP®
#COVID19
Antigen Test, being developed for the Chembio DPP® Micro Reader II with actionable results in 15-20 minutes
8
8
27
BARDA and
@US_FDA
will host a virtual workshop titled Recombinant Protein-Based COVID-19 Vaccines on April 27, 2023, from 9:00 am EDT to 1:00 pm EDT. To register, visit:
11
6
30
Congratulations to our long-standing partner,
@JanssenUS
, on their
#COVID19
vaccine EUA. Janssen was the first of seven
#COVID19
vaccine programs supported by BARDA.
2
6
28
We are proud to partner with
@MayoClinic
in concert with
@US_FDA
guidance to fight
#COVID19
. More than 48,500 patients have been transfused with convalescent plasma as part of this BARDA-supported program.
4
12
26
We’re partnering w/
@JPEOCBRND
,
@Sanofi
, &
@GSK
under
#WarpSpeed
to develop & produce an investigational adjuvanted
#COVID19
vaccine, including a demo of large-scale vaccine manufacturing w/ an adjuvant to enhance vaccine effectiveness.
6
14
27
@SecAzar
@POTUS
BARDA is honored to support
@POTUS
’s initiative to help
#SaveLives
in an influenza
#pandemic
by working, through
#PublicPrivatePartnerships
, to modernize influenza vaccines that strengthen
#HealthSecurity
.
0
5
18
We’re excited to announce that
#DRIVe
is teaming up with an academic consortium, led by
@EmoryMedicine
,
@emorybmi
, to further develop
#deeplearning
software to provide early warning of
#sepsis
in patients.
#DRIVeInnovation
#SolvingSepsis
#MachineLearning
1
25
29
To ensure communities are protected against infectious diseases, we’re partnering to advance vaccine delivery methods, enhance vaccine storage capability, support vaccine research & development for safe, effective, accessible vaccines.
Learn more:
14
11
28
This
#NPM2023
and year-round, we’re working with
@NIAIDNews
on
#ProjectNextGen
to strengthen vaccine capabilities against current & future
#COVID19
strains & variants.
8
6
27
We are proud to announce the latest addition to our growing portfolio of
#COVID19
medical countermeasure development projects! BARDA will partner with
@JanssenUS
on the development of a new therapeutic product to treat patients with
#COVID19
.
0
9
28
Today marks the start of World Antimicrobial Awareness Week 2020
#WAAW
. Each year, more than 2.8 million Americans develop drug-resistant infections and more than 35,000 die from them. Learn what BARDA is doing to combat
#AntibioticResistance
#AntibioticResistance
is one of the most urgent global threats to the public’s health. Any time
#antibiotics
are used, they can cause side effects and contribute to the development of antibiotic resistance.
#WAAW
9
92
186
2
12
27
🆕 Announcing
#BARDAVentures
! We are seeking a nonprofit partner to operate & manage a venture-style partnership of breakthrough technologies focused on advancing
#HealthSecurity
.
#DRIVeInnovation
#VC
#VentureCapital
2
7
27
BARDA and
@Crossject_
are working together to advance
#HealthSecurity
&
#preparedness
against nerve agent attacks. Under Project BioShield, we are developing a more efficacious & needle-free autoinjector seizure treatment for both children & adults:
1
13
25
One goal of our 2022-2026 Strategic Plan is to maintain a mission-ready response posture. To support this, BARDA is increasing U.S. manufacturing capabilities to produce
#medicalcountermeasures
at the scale needed for future
#publichealth
emergencies:
5
3
27
We are excited that long-standing partner
@Regeneron
has received
@US_FDA
approval of the first safe, effective treatment for
#Ebola
. Inmazeb® is an anti-viral antibody ‘cocktail’ for the treatment of infection caused by Zaire ebolavirus in adult and pediatric patients.
2
7
26
For this AOI, next generation vaccines include those with enhanced breadth of protection against variants, improved durability, and those with an enhanced ability to block infection/transmission including mucosal vaccines, relative to currently approved vaccines.
7
8
27
Through
#ProjectNextGen
, BARDA and
@NIAIDNews
are leveraging
#PublicPrivatePartnerships
to advance the development of MCMs, including vaccines & therapeutics, to better protect people in communities nationwide from current & future variants of SARS-CoV-2:
4
9
26
🆕
#ProjectNextGen
opportunity under the
@RRPV_Consortium
. Interested in supporting the development of manufacturing technologies that can produce on demand vaccines & therapeutics against
#COVID19
& other
#HealthSecurity
threats? Submit abstracts by 9/25:
9
5
26
Coming soon! To address the growing threat of
#AntibioticResistance
, BARDA will be hosting a virtual workshop in early 2021 to better understand the AMR vaccine landscape of 4 targeted pathogens: E. coli (urinary), K. pneumonia, P. aeruginosa, & S. aureus.
#WAAW
0
6
25
This
#NationalPreparednessMonth
, we’re recognizing the steps BARDA has taken to
#BeReady
to mitigate the impact of potential pandemic influenza viruses. W/ our partners, we work to provide timely, continuous updates of stockpiled vaccines...
1
8
26
Our partner
@CARB_X
is seeking vaccines, antibiotics, rapid diagnostics & other medical countermeasures to detect, prevent, or treat antimicrobial resistant bacterial infections. The deadline to submit is Jan 30, 2023 @ 23:59 ET:
0
17
26
Just Launched: Pediatric COVID-19 Data Challenge with
@NCATS_NIH_gov
,
@HRSAgov
,
@NICHD_NIH
. Help clinicians predict which among their pediatric patients will develop severe COVID-19 complications, including conditions like MIS-C. Read more:
0
19
24
The
@US_FDA
has issued EUA for
@Moderna_tx
’s mRNA
#COVID19
vaccine. Co-developed w/scientists at
@NIAIDnews
, BARDA, & Moderna, this innovative partnership has developed a safe & effective COVID-19 vaccine within a year. Read more:
1
6
23
Today at the
#BLUEKNIGHT
Symposium, BARDA and
@JNJInnovation
(
@JLABS
) announced the BLUE KNIGHT QuickFire Challenge: Accelerating Project NextGen. Applications due June 30, 2023. Learn more about the challenge and apply:
3
7
24
Take a behind-the-scenes look at medical countermeasure research, development & manufacturing programs that BARDA’s partners have undertaken to fight the
#COVID19
pandemic! Join us as we embark on the
#MakingCountermeasures
series! Check back daily for updates.
9
8
23
Under
#ProjectNextGen
, BARDA seeks information on the potential use of “pull incentives” to drive
#COVID19
vaccine development and commercialization, including in partnership with other sponsoring organizations. Respond to our RFI by 8/10:
4
3
25
📣 Our BID Day 2 Breakout Sessions will cover BARDA’s efforts in supporting the innovation and advancement of
#medicalcountermeasure
development and national preparedness. There will also be opportunities to connect with stakeholders about funding and possible partnerships.
0
10
24
BARDA is committed to innovation and the establishment of novel
#publicprivatepartnerships
. These new models enable us to bring the best ideas from the medical, scientific, biotech, and business communities to catalyze the
#HealthSecurity
field.
#BIO2019
#PoweredByBARDA
0
8
23
A comprehensive study by BARDA,
@CMSgov
& Acumen LLC finds that sepsis is more common and costly than previously understood. Find out how the burden of
#sepsis
threatens everyday health,
#HealthSecurity
, and our economy.
#SolvingSepsisTogether
2
21
24
#COVID19
can lead to viral
#sepsis
. BARDA is working with its partners on
#SolvingSepsisTogether
to help diagnose sepsis to
#SaveLives
and improve patient outcomes.
5
10
23
We are proud to partner with
@nanomixinc
to develop a rapid and accurate
#COVID19
diagnostic for use in near-patient settings – with results in just 15 minutes
3
7
21
A new Stewardship & Access Plan Development Guide, developed by
@wellcometrust
in partnership with
@CARB_X
, can help product developers strategize to facilitate faster & broader access to innovative antibacterials while fostering
#antibiotic
stewardship.
1
8
24